This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

For patients with asymptomatic severe aortic stenosis, transcatheter aortic valve replacement was superior to clinical ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal condition ...

a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe aortic stenosis without symptoms. The approval is the first for TAVR in asymptomatic patients. In the EARLY TAVR ...

Find out why staging TAVI and PCI lowers risk in complex heart cases - read the latest insights from the ASCoP registry.

“Aortic stenosis is a common yet dangerous heart condition." “It happens when the aortic valve, the main outflow valve of the heart, stiffens and narrows. This causes reduced blood flow from the heart ...